[MDGL] QoQ Quarter Result on 31-Dec-2021 [#Q4]

Stock
[MDGL] Madrigal Pharmaceuticals, Inc.
Announcement Date
24-Feb-2022
Financial Year
2021
Quarter
31-Dec-2021 [#Q4]
Profit Trend
QoQ- -2.30%
YoY- -9.18%
Quarter Report
MDGL's Result
MDGL's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -81,197 -70,730 -57,518 -64,549 -63,100 -61,651 -52,546 33.62%
Tax 1,502 780 69 -106 0 0 -160 -
NP -82,699 -71,510 -57,587 -64,549 -63,100 -61,651 -52,546 35.26%
Tax Rate - - - - - - - -
Total Cost 82,699 71,510 57,587 64,549 63,100 61,651 52,546 35.26%
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
EPS -4.84 -4.18 -3.37 -3.78 -3.79 -3.72 -3.32 28.54%
EPS Diluted -4.84 -4.18 -3.37 -3.78 -3.79 -3.72 -3.32 28.54%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.